1. Home
  2. OLMA vs VEON Comparison

OLMA vs VEON Comparison

Compare OLMA & VEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • VEON
  • Stock Information
  • Founded
  • OLMA 2006
  • VEON 1992
  • Country
  • OLMA United States
  • VEON United Arab Emirates
  • Employees
  • OLMA N/A
  • VEON N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • VEON Telecommunications Equipment
  • Sector
  • OLMA Health Care
  • VEON Telecommunications
  • Exchange
  • OLMA Nasdaq
  • VEON Nasdaq
  • Market Cap
  • OLMA 299.7M
  • VEON 2.7B
  • IPO Year
  • OLMA 2020
  • VEON 1996
  • Fundamental
  • Price
  • OLMA $4.63
  • VEON $53.55
  • Analyst Decision
  • OLMA Strong Buy
  • VEON Strong Buy
  • Analyst Count
  • OLMA 4
  • VEON 1
  • Target Price
  • OLMA $24.50
  • VEON $60.00
  • AVG Volume (30 Days)
  • OLMA 827.7K
  • VEON 282.6K
  • Earning Date
  • OLMA 08-05-2025
  • VEON 08-07-2025
  • Dividend Yield
  • OLMA N/A
  • VEON N/A
  • EPS Growth
  • OLMA N/A
  • VEON N/A
  • EPS
  • OLMA N/A
  • VEON 6.56
  • Revenue
  • OLMA N/A
  • VEON $4,088,000,000.00
  • Revenue This Year
  • OLMA N/A
  • VEON $7.32
  • Revenue Next Year
  • OLMA N/A
  • VEON $6.68
  • P/E Ratio
  • OLMA N/A
  • VEON $8.21
  • Revenue Growth
  • OLMA N/A
  • VEON 8.84
  • 52 Week Low
  • OLMA $2.86
  • VEON $25.92
  • 52 Week High
  • OLMA $16.62
  • VEON $59.68
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 55.54
  • VEON 67.42
  • Support Level
  • OLMA $4.60
  • VEON $42.54
  • Resistance Level
  • OLMA $5.01
  • VEON $59.68
  • Average True Range (ATR)
  • OLMA 0.27
  • VEON 2.70
  • MACD
  • OLMA 0.05
  • VEON 1.43
  • Stochastic Oscillator
  • OLMA 77.50
  • VEON 69.52

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About VEON VEON Ltd. ADS

VEON Ltd is a United Arab Emirates-based digital operator providing connectivity and Internet services to corporations and individuals. The company offers mobile and fixed-line telecommunications services through a range of traditional and broadband mobile technologies. The company's reportable segments consist of the following five segments: Pakistan, Ukraine, Kazakhstan, Bangladesh, and Uzbekistan. It provides its services under the Beeline, Kyivstar, Banglalink, and Jazz brands. It generates the majority of its revenue from Pakistan.

Share on Social Networks: